271 related articles for article (PubMed ID: 6147364)
1. Mepacrine-induced elevation of cyclic GMP levels and acceleration of reversal of ADP-induced aggregation in washed rabbit platelets.
Matsuoka I; Suzuki T
J Cyclic Nucleotide Protein Phosphor Res; 1983; 9(4-5):341-53. PubMed ID: 6147364
[TBL] [Abstract][Full Text] [Related]
2. Mepacrine-induced inhibition of human platelet cyclic-GMP phosphodiesterase.
Yamakado T; Tanaka F; Hidaka H
Biochim Biophys Acta; 1984 Sep; 801(1):111-6. PubMed ID: 6147162
[TBL] [Abstract][Full Text] [Related]
3. Molecular basis of the synergistic inhibition of platelet function by nitrovasodilators and activators of adenylate cyclase: inhibition of cyclic AMP breakdown by cyclic GMP.
Maurice DH; Haslam RJ
Mol Pharmacol; 1990 May; 37(5):671-81. PubMed ID: 2160060
[TBL] [Abstract][Full Text] [Related]
4. Cyclic GMP binding and phosphodiesterase: implication for platelet function.
Hamet P; Coquil JF; Bousseau-Lafortune S; Franks DJ; Tremblay J
Adv Cyclic Nucleotide Protein Phosphorylation Res; 1984; 16():119-36. PubMed ID: 6202123
[No Abstract] [Full Text] [Related]
5. Inhibition of human platelet aggregation by S-nitrosothiols. Heme-dependent activation of soluble guanylate cyclase and stimulation of cyclic GMP accumulation.
Mellion BT; Ignarro LJ; Myers CB; Ohlstein EH; Ballot BA; Hyman AL; Kadowitz PJ
Mol Pharmacol; 1983 May; 23(3):653-64. PubMed ID: 6135148
[TBL] [Abstract][Full Text] [Related]
6. Effect of 1-(3-chloroanilino)-4-phenylphthalazine (MY-5445), a specific inhibitor of cyclic GMP phosphodiesterase, on human platelet aggregation.
Hagiwara M; Endo T; Kanayama T; Hidaka H
J Pharmacol Exp Ther; 1984 Feb; 228(2):467-71. PubMed ID: 6141286
[TBL] [Abstract][Full Text] [Related]
7. The effect of phospholipase inhibitor mepacrine on platelet aggregation, the platelet release reaction and fibrinogen binding to the platelet surface.
Winocour PD; Kinlough-Rathbone RL; Mustard JF
Thromb Haemost; 1981 Jun; 45(3):257-62. PubMed ID: 7281105
[TBL] [Abstract][Full Text] [Related]
8. Cyclic nucleotide phosphodiesterase activity and the platelet release reaction.
Taylor PM; Heptinstall S
Thromb Haemost; 1978 Apr; 39(2):550-1. PubMed ID: 27878
[No Abstract] [Full Text] [Related]
9. Inhibition of platelet aggregation and stimulation of guanylate cyclase by an antianginal agent molsidomine and its metabolites.
Nishikawa M; Kanamori M; Hidaka H
J Pharmacol Exp Ther; 1982 Jan; 220(1):183-90. PubMed ID: 6118429
[No Abstract] [Full Text] [Related]
10. [The role of guanyl cyclase in the regulation of aggregation of human thrombocytes].
Chirkov IuIu; Belushkina NN; Tyshchuk IA; Severina IS
Vestn Akad Med Nauk SSSR; 1991; (10):51-4. PubMed ID: 1686950
[TBL] [Abstract][Full Text] [Related]
11. Selective inhibitor of platelet cyclic adenosine monophosphate phosphodiesterase, cilostamide, inhibits platelet aggregation.
Hidaka H; Hayashi H; Kohri H; Kimura Y; Hosokawa T; Igawa T; Saitoh Y
J Pharmacol Exp Ther; 1979 Oct; 211(1):26-30. PubMed ID: 226672
[No Abstract] [Full Text] [Related]
12. Cyclic AMP and cyclic GMP phosphodiesterase inhibition by an antiplatelet agent, 6-[(3-methylene-2-oxo-5-phenyl-5-tetrahydrofuranyl)methoxy)quinol inone (CCT-62).
Liao CH; Tzeng CC; Teng CM
Eur J Pharmacol; 1998 May; 349(1):107-14. PubMed ID: 9669503
[TBL] [Abstract][Full Text] [Related]
13. Effect of cAMP phosphodiesterase inhibitors on ADP-induced shape change, cAMP and nucleoside diphosphokinase activity of rabbit platelets.
Lam SC; Guccione MA; Packham MA; Mustard JF
Thromb Haemost; 1982 Apr; 47(2):90-5. PubMed ID: 6285543
[TBL] [Abstract][Full Text] [Related]
14. ADP-mimicking platelet aggregation caused by rugosin E, an ellagitannin isolated from Rosa rugosa Thunb.
Teng CM; Kang YF; Chang YL; Ko FN; Yang SC; Hsu FL
Thromb Haemost; 1997 Mar; 77(3):555-61. PubMed ID: 9066010
[TBL] [Abstract][Full Text] [Related]
15. In vitro effect of a thymic epithelial culture supernate or thymosin fraction 5 on rabbit platelet aggregation and intracellular cyclic AMP levels.
Hashimoto S; Itoh Y; Kawaguchi A; Mizuno Y; Muraoka M; Tsuchiya M
J Cell Physiol; 1987 Dec; 133(3):499-506. PubMed ID: 2826498
[TBL] [Abstract][Full Text] [Related]
16. The involvement of prostaglandin endoperoxide formation in the elevation of cyclic GMP levels during platelet aggregation.
Glass DB; Gerrard JM; Townsend D; Carr DW; White JG; Goldberg ND
J Cyclic Nucleotide Res; 1977 Feb; 3(1):37-44. PubMed ID: 191476
[TBL] [Abstract][Full Text] [Related]
17. Increase in reactivity of human platelet guanylate cyclase during aggregation potentiates the disaggregating capacity of sodium nitroprusside.
Chirkov YY; Belushkina NN; Tyshchuk IA; Severina IS; Horowitz JD
Clin Exp Pharmacol Physiol; 1991 Jul; 18(7):517-24. PubMed ID: 1680588
[TBL] [Abstract][Full Text] [Related]
18. Evidence for a cyclic GMP-independent mechanism in the anti-platelet action of S-nitrosoglutathione.
Gordge MP; Hothersall JS; Noronha-Dutra AA
Br J Pharmacol; 1998 May; 124(1):141-8. PubMed ID: 9630353
[TBL] [Abstract][Full Text] [Related]
19. Control of platelet activation by cyclic AMP turnover and cyclic nucleotide phosphodiesterase type-3.
Feijge MA; Ansink K; Vanschoonbeek K; Heemskerk JW
Biochem Pharmacol; 2004 Apr; 67(8):1559-67. PubMed ID: 15041473
[TBL] [Abstract][Full Text] [Related]
20. Intracellular levels of cyclic AMP and cyclic GMP differentially modify platelet aggregate size in human platelets activated with epinephrine or ADP.
Qi R; Ozaki Y; Satoh K; Yang LB; Asazuma N; Yatomi Y; Kume S
J Cardiovasc Pharmacol; 1996 Aug; 28(2):215-22. PubMed ID: 8856476
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
